Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. The company is headquartered in Cambridge, Massachusetts and currently employs 7,800 full-time employees. The firm focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The firm markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). The company also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The firm's product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.

Mr. Adam  Keeney Ph.D.

Executive Vice President & Head of Corporate Development

Mr. Christopher A. Viehbacher

President, Chief Executive Officer & Director

Mr. Michael R. McDonnell CPA

Executive Vice President & Chief Financial Officer

Mr. Charles E. Triano

Senior Vice President & Head of Investor Relations

Ms. Natacha  Gassenbach

Chief Communication Officer & Head of Corporate Affairs

Ms. Nicole  Murphy

Head of Pharmaceutical Operations & Technology

Ms. Robin C. Kramer

Senior Vice President & Chief Accounting Officer

Ms. Susan H. Alexander Esq.

Executive Vice President & Chief Legal Officer

Dr. Ginger  Gregory Ph.D.

Executive Vice President & Chief Human Resources Officer

Mr. Rachid  Izzar

Head of Global Product Strategy & Commercialization

Nimi	Markkinakapasiteetti
Affimed N.V.	0M
Halozyme Therapeutics, Inc.	0M
Homology Medicines, Inc.	0M
Leafly Holdings, Inc.	0M
Walgreens Boots Alliance Inc	0M
Transgene SA	0M
Nektar Therapeutics	0M
Satudora Holdings Co.,Ltd.	0M
Camurus AB (publ)	0M
NEUCA S.A.	0M
Walgreens Boots Alliance, Inc.	0M

Biogen Inc

Biogen Inc Kilpailijaluettelo

Tärkeimmät kilpailijat